KSS leads the way in detecting undiagnosed Atrial Fibrillation
Health care professionals across Kent, Surrey and Sussex are topping the tables when it comes to detecting undiagnosed Atrial Fibrillation (AF).
Through our 'Detect. Review. Protect' project we have issued more than 500 Lead 1 ECG devices to a range of settings across our region.
The portable devices are being used by a range of professionals, including health care assistants, GPs, pharmacists and nurses, to take an instant heart trace to determine whether an individual has AF – a major cause of stroke.
The work is part of a national programme, and national data just released shows that Kent, Surrey and Sussex is out-performing every other region when it comes to detecting possible AF.
By the end of 2018, 6,415 individual ECG traces had been taken across Kent, Surrey and Sussex. Of these, 607 possible cases of AF were detected, which equates to approximately 24 AF-related strokes being saved.
As well as avoiding debilitating effects on individuals and their families (provided all possible AF results are confirmed AF and individuals receive the correct anti-coagulation therapy) this equates to state-funded Health and Social Care services avoiding costs of £1,000,000 over five years, based on KSS AHSN return on investment methodology.
Jen Bayly, Cardiovascular Lead at KSS AHSN, said estimates show there are up to 25,000 people living with undiagnosed AF across Kent, Surrey and Sussex.
"It's vital that we find those living with undiagnosed AF so that they can get the appropriate medication to reduce their stroke risk," she added.
"We've seen great enthusiasm and commitment to this project across Kent, Surrey and Sussex, and these figures pay testament to the hard work of all involved."